These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 7767315

  • 1. Regional brain uptake and pharmacokinetics of [123I]N-omega-fluoroalkyl-2 beta-carboxy-3 beta-(4-iodophenyl)nortropane esters in baboons.
    Baldwin RM, Zea-Ponce Y, al-Tikriti MS, Zoghbi SS, Seibyl JP, Charney DS, Hoffer PB, Wang S, Milius RA, Neumeyer JL.
    Nucl Med Biol; 1995 Feb; 22(2):211-9. PubMed ID: 7767315
    [Abstract] [Full Text] [Related]

  • 2. SPECT imaging of dopamine transporters in human brain with iodine-123-fluoroalkyl analogs of beta-CIT.
    Abi-Dargham A, Gandelman MS, DeErausquin GA, Zea-Ponce Y, Zoghbi SS, Baldwin RM, Laruelle M, Charney DS, Hoffer PB, Neumeyer JL, Innis RB.
    J Nucl Med; 1996 Jul; 37(7):1129-33. PubMed ID: 8965183
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of the monoamine uptake site ligand [123I]methyl 3 beta-(4-iodophenyl)-tropane-2 beta-carboxylate ([123I]beta-CIT) in non-human primates: pharmacokinetics, biodistribution and SPECT brain imaging coregistered with MRI.
    Baldwin RM, Zea-Ponce Y, Zoghbi SS, Laurelle M, al-Tikriti MS, Sybirska EH, Malison RT, Neumeyer JL, Milius RA, Wang S.
    Nucl Med Biol; 1993 Jul; 20(5):597-606. PubMed ID: 8358345
    [Abstract] [Full Text] [Related]

  • 4. Iodine-123 labelled N-(2-fluoroethyl)-2 beta-carbomethoxy-3 beta-(4-iodophenyl)nortropane for dopamine transporter imaging in the living human brain.
    Kuikka JT, Akerman K, Bergström KA, Karhu J, Hiltunen J, Haukka J, Heikkinen J, Tiihonen J, Wang S, Neumeyer JL.
    Eur J Nucl Med; 1995 Jul; 22(7):682-6. PubMed ID: 7498231
    [Abstract] [Full Text] [Related]

  • 5. Human biodistribution and dosimetry of [123I]FP-CIT: a potent radioligand for imaging of dopamine transporters.
    Booij J, Busemann Sokole E, Stabin MG, Janssen AG, de Bruin K, van Royen EA.
    Eur J Nucl Med; 1998 Jan; 25(1):24-30. PubMed ID: 9396871
    [Abstract] [Full Text] [Related]

  • 6. Whole-body biodistribution, radiation absorbed dose and brain SPECT imaging with iodine-123-beta-CIT in healthy human subjects.
    Seibyl JP, Wallace E, Smith EO, Stabin M, Baldwin RM, Zoghbi S, Zea-Ponce Y, Gao Y, Zhang WY, Neumeyer JL.
    J Nucl Med; 1994 May; 35(5):764-70. PubMed ID: 8176456
    [Abstract] [Full Text] [Related]

  • 7. Human biodistribution and dosimetry of iodine-123-fluoroalkyl analogs of beta-CIT.
    Abi-Dargham A, Innis RB, Wisniewski G, Baldwin RM, Neumeyer JL, Seibyl JP.
    Eur J Nucl Med; 1997 Nov; 24(11):1422-5. PubMed ID: 9371877
    [Abstract] [Full Text] [Related]

  • 8. Comparison of [123I]beta-CIT and [123I]IPCIT as single-photon emission tomography radiotracers for the dopamine transporter in nonhuman primates.
    Scanley BE, al-Tikriti MS, Gandelman MS, Laruelle M, Zea-Ponce Y, Baldwin RM, Zoghbi SS, Hoffer PB, Charney DS, Wang S.
    Eur J Nucl Med; 1995 Jan; 22(1):4-11. PubMed ID: 7698153
    [Abstract] [Full Text] [Related]

  • 9. [Metabolism of 123I-FP-CIT in humans].
    Tanaka A, Okano K, Tamagami H, Matsumoto H, Tanifuji S, Yamamichi Y, Yoshimura H, Katoazuma M, Takano K, Matsumura K, Takeda K.
    Kaku Igaku; 1999 Sep; 36(7):745-51. PubMed ID: 10547984
    [Abstract] [Full Text] [Related]

  • 10. Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients.
    Seibyl JP, Marek K, Sheff K, Zoghbi S, Baldwin RM, Charney DS, van Dyck CH, Innis RB.
    J Nucl Med; 1998 Sep; 39(9):1500-8. PubMed ID: 9744331
    [Abstract] [Full Text] [Related]

  • 11. Measurement of [123I]FP-CIT binding to the dopamine transporter (DAT) in healthy mouse striatum using dedicated small animal SPECT imaging: feasibility, optimization and validation.
    Greco A, Zannetti A, Pappatà S, Albanese S, Coda AR, Ragucci M, Nardelli A, Brunetti A, Cuocolo A, Salvatore M.
    Q J Nucl Med Mol Imaging; 2018 Mar; 62(1):112-117. PubMed ID: 26329495
    [Abstract] [Full Text] [Related]

  • 12. Comparison of iodine-123 labelled 2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and 2 beta-carbomethoxy-3 beta-(4-iodophenyl)-N-(3-fluoropropyl)nortropane for imaging of the dopamine transporter in the living human brain.
    Kuikka JT, Bergström KA, Ahonen A, Hiltunen J, Haukka J, Länsimies E, Wang S, Neumeyer JL.
    Eur J Nucl Med; 1995 Apr; 22(4):356-60. PubMed ID: 7607268
    [Abstract] [Full Text] [Related]

  • 13. [123I]FP-CIT binds to the dopamine transporter as assessed by biodistribution studies in rats and SPECT studies in MPTP-lesioned monkeys.
    Booij J, Andringa G, Rijks LJ, Vermeulen RJ, De Bruin K, Boer GJ, Janssen AG, Van Royen EA.
    Synapse; 1997 Nov; 27(3):183-90. PubMed ID: 9329154
    [Abstract] [Full Text] [Related]

  • 14. Imaging serotonin and dopamine transporters with 123I-beta-CIT SPECT: binding kinetics and effects of normal aging.
    Pirker W, Asenbaum S, Hauk M, Kandlhofer S, Tauscher J, Willeit M, Neumeister A, Praschak-Rieder N, Angelberger P, Brücke T.
    J Nucl Med; 2000 Jan; 41(1):36-44. PubMed ID: 10647603
    [Abstract] [Full Text] [Related]

  • 15. Chronic motor cortex stimulation in patients with advanced Parkinson's disease and effects on striatal dopaminergic transmission as assessed by 123I-FP-CIT SPECT: a preliminary report.
    Di Giuda D, Calcagni ML, Totaro M, Cocciolillo F, Piano C, Soleti F, Fasano A, Cioni B, Bentivoglio AR, Giordano A.
    Nucl Med Commun; 2012 Sep; 33(9):933-40. PubMed ID: 22735298
    [Abstract] [Full Text] [Related]

  • 16. Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease.
    Booij J, Habraken JB, Bergmans P, Tissingh G, Winogrodzka A, Wolters EC, Janssen AG, Stoof JC, van Royen EA.
    J Nucl Med; 1998 Nov; 39(11):1879-84. PubMed ID: 9829575
    [Abstract] [Full Text] [Related]

  • 17. Characterization of the dopamine transporter in nonhuman primate brain: homogenate binding, whole body imaging, and ex vivo autoradiography using [125I] and [123I]IPCIT.
    al-Tikriti MS, Zea-Ponce Y, Baldwin RM, Zoghbi SS, Laruelle M, Seibyl JP, Giddings SS, Scanley BE, Charney DS, Hoffer PB.
    Nucl Med Biol; 1995 Jul; 22(5):649-58. PubMed ID: 7581176
    [Abstract] [Full Text] [Related]

  • 18. Use of 11C-PE2I PET in differential diagnosis of parkinsonian disorders.
    Appel L, Jonasson M, Danfors T, Nyholm D, Askmark H, Lubberink M, Sörensen J.
    J Nucl Med; 2015 Feb; 56(2):234-42. PubMed ID: 25593112
    [Abstract] [Full Text] [Related]

  • 19. Active and inactive enantiomers of 2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane: comparison using homogenate binding and single photon emission computed tomographic imaging.
    Scanley BE, Baldwin RM, Laruelle M, al-Tikriti MS, Zea-Ponce Y, Zoghbi S, Giddings SS, Charney DS, Hoffer PB, Wang S.
    Mol Pharmacol; 1994 Jan; 45(1):136-41. PubMed ID: 8302272
    [Abstract] [Full Text] [Related]

  • 20. [Phase 1 clinical study of 123I-FP-CIT, a new radioligand for evaluating dopamine transporter with SPECT (I): Biodistribution and absorbed dose].
    Takano K, Matsumura K, Watanabe Y, Yamada T, Kubo H, Naitou Y, Narita Y, Kuzuhara S, Takeda K.
    Kaku Igaku; 1999 Sep; 36(7):735-44. PubMed ID: 10547983
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.